There is currently a shortage of EpiPen auto-injectors in the 0.3 mg format (DIN 00509558) in Canada due to a manufacturing disruption. The shortage is anticipated to be resolved by March 2, 2018.
What pharmacy professionals need to know
While Pfizer is working closely with its distributors to resolve the shortage as soon as possible, it expects a period of between two and four weeks of no inventory of the 0.3 mg format. Pfizer has advised that additional limited inventory will be available at the beginning of February 2018 and that it will continue to manage supply carefully. Pfizer is asking pharmacists to keep this supply interruption in mind when filling prescriptions.
According to Pfizer, the shortage does not impact EpiPen Jr (0.15 mg) products, which remain available.
For further information on the shortage, please read:
Patients are encouraged to visit drugshortagescanada.ca or contact Pfizer for up-to-date information about the shortage and estimated re-supply dates. Patients with questions or concerns are also encouraged to speak with their pharmacist, or other member of their healthcare team.